The Lancet Gastroenterology & Hepatology in conversation with Podcast Artwork Image

The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Group

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Episodes
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intakeMarch 12, 2024
Episode artwork
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivityMarch 01, 2024
Episode artwork
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific regionDecember 19, 2023
Episode artwork
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomyNovember 29, 2023
Episode artwork
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver diseaseOctober 12, 2023
Episode artwork
Robert Krouse on surgical versus non-surgical management of malignant bowel obstructionSeptember 13, 2023
Episode artwork
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritisAugust 10, 2023
Episode artwork
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver diseaseJuly 12, 2023
Episode artwork
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosisJune 07, 2023
Episode artwork
Adelina Artenie on the incidence of HIV and HCV in people who inject drugsMay 10, 2023
Episode artwork
Johan Burisch on the costs of inflammatory bowel disease in high-income settingsApril 12, 2023
Episode artwork
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s diseaseFebruary 08, 2023
Episode artwork
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancerJanuary 23, 2023
Episode artwork
Dan Turner on vedolizumab in children with IBDJanuary 06, 2023
Episode artwork
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infectionNovember 09, 2022
Episode artwork
James Alexander on immune responses to COVID-19 vaccination in patients with IBDOctober 05, 2022
Episode artwork
Filip Knop on liraglutide for bile acid diarrhoeaSeptember 07, 2022
Episode artwork
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinomaAugust 04, 2022
Episode artwork
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancerJuly 06, 2022
Episode artwork
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulasJune 14, 2022
Episode artwork
Juan Pablo Arab on NAFLD public health policies in the AmericasMay 09, 2022
Episode artwork
Sarah Blach on hepatitis C virus epidemiologyApril 06, 2022
Episode artwork
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infectionMarch 23, 2022
Episode artwork
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitisMarch 09, 2022
Episode artwork
Swati Patel on early-onset colorectal cancerFebruary 09, 2022
Episode artwork